|
WO1981001145A1
(en)
|
1979-10-18 |
1981-04-30 |
Univ Illinois |
Hydrolytic enzyme-activatible pro-drugs
|
|
US4698420A
(en)
|
1985-02-25 |
1987-10-06 |
Xoma Corporation |
Antibody hybrid molecules and process for their preparation
|
|
US6214345B1
(en)
|
1993-05-14 |
2001-04-10 |
Bristol-Myers Squibb Co. |
Lysosomal enzyme-cleavable antitumor drug conjugates
|
|
ATE283855T1
(de)
|
1996-07-03 |
2004-12-15 |
Sumitomo Pharma |
Neue purinderivate
|
|
TW572758B
(en)
|
1997-12-22 |
2004-01-21 |
Sumitomo Pharma |
Type 2 helper T cell-selective immune response inhibitors comprising purine derivatives
|
|
US7425541B2
(en)
|
1998-12-11 |
2008-09-16 |
Medarex, Inc. |
Enzyme-cleavable prodrug compounds
|
|
IL148079A0
(en)
|
1999-08-24 |
2002-09-12 |
Medarex Inc |
Human ctla-4 antibodies and compositions containing the same
|
|
WO2002015700A1
(en)
|
2000-08-24 |
2002-02-28 |
Coulter Pharmaceutical, Inc. |
Prodrugs activated by plasmin and their use in cancer chemotherapy
|
|
US7571211B1
(en)
|
2002-04-15 |
2009-08-04 |
Lightwaves Systems, Inc. |
Method for routing messages over a network based on location
|
|
US7157465B2
(en)
|
2001-04-17 |
2007-01-02 |
Dainippon Simitomo Pharma Co., Ltd. |
Adenine derivatives
|
|
US7129261B2
(en)
|
2001-05-31 |
2006-10-31 |
Medarex, Inc. |
Cytotoxic agents
|
|
DE60239679D1
(de)
|
2001-06-11 |
2011-05-19 |
Medarex Inc |
Methode für die ausarbeitung von cd10-aktivierten prodrug-verbindungen
|
|
US7091186B2
(en)
|
2001-09-24 |
2006-08-15 |
Seattle Genetics, Inc. |
p-Amidobenzylethers in drug delivery agents
|
|
US7241890B2
(en)
|
2001-10-30 |
2007-07-10 |
Conforma Therapeutics Corporation |
Purine analogs having HSP90-inhibiting activity
|
|
EP1471938A4
(en)
|
2002-01-09 |
2008-03-05 |
Medarex Inc |
HUMAN MONOCLONAL ANTIBODIES AGAINST CD30
|
|
AU2003271064B2
(en)
|
2002-09-27 |
2010-06-17 |
Dainippon Sumitomo Pharma Co., Ltd. |
Novel adenine compound and use thereof
|
|
JP2004137157A
(ja)
|
2002-10-16 |
2004-05-13 |
Sumitomo Pharmaceut Co Ltd |
新規アデニン誘導体を有効成分として含有する医薬
|
|
ATE459647T1
(de)
|
2003-04-15 |
2010-03-15 |
Glaxosmithkline Llc |
Humane il-18 substitutionsmutanten und deren konjugate
|
|
GT200400138A
(es)
|
2003-07-22 |
2005-03-22 |
|
Anticuerpos rgi y uso de los mismos.
|
|
WO2005051976A2
(en)
|
2003-11-20 |
2005-06-09 |
Ansata Therapeutics, Inc. |
Protein and peptide ligation processes and one-step purification processes
|
|
RS53984B1
(sr)
|
2003-12-10 |
2015-10-30 |
E. R. Squibb & Sons L.L.C. |
Ip-10 antitela i njihove upotrebe
|
|
EP1718667B1
(en)
|
2004-02-23 |
2013-01-09 |
Genentech, Inc. |
Heterocyclic self-immolative linkers and conjugates
|
|
EP1737890A2
(en)
|
2004-03-24 |
2007-01-03 |
Xencor, Inc. |
Immunoglobulin variants outside the fc region
|
|
US20070225303A1
(en)
|
2004-03-26 |
2007-09-27 |
Haruhisa Ogita |
8-Oxoadenine Compound
|
|
JP4806680B2
(ja)
|
2004-05-19 |
2011-11-02 |
メダレックス インコーポレイテッド |
自己犠牲リンカー及び薬剤複合体
|
|
RU2402548C2
(ru)
|
2004-05-19 |
2010-10-27 |
Медарекс, Инк. |
Химические линкеры и их конъюгаты
|
|
KR101270829B1
(ko)
|
2004-09-23 |
2013-06-07 |
제넨테크, 인크. |
시스테인 유전자조작 항체 및 접합체
|
|
JP2008517994A
(ja)
*
|
2004-10-28 |
2008-05-29 |
ファルマシア・アンド・アップジョン・カンパニー・エルエルシー |
新規医薬品
|
|
BRPI0607796A2
(pt)
|
2005-02-18 |
2009-06-13 |
Medarex Inc |
composto ou um sal farmaceuticamente aceitável do mesmo, processo para preparação e uso do mesmo, e, composição farmacêutica
|
|
NZ556661A
(en)
|
2005-02-18 |
2010-10-29 |
Medarex Inc |
Human monoclonal antibodies to prostate specific membrance antigen (PSMA)
|
|
US7714016B2
(en)
|
2005-04-08 |
2010-05-11 |
Medarex, Inc. |
Cytotoxic compounds and conjugates with cleavable substrates
|
|
EP1888587A1
(en)
|
2005-05-04 |
2008-02-20 |
Pfizer Limited |
2-amido-6-amino-8-oxopurine derivatives as toll-like receptor modulators for the treatment of cancer and viral infections, such as hepatitis c
|
|
RU2494107C2
(ru)
|
2005-05-09 |
2013-09-27 |
Оно Фармасьютикал Ко., Лтд. |
Моноклональные антитела человека к белку программируемой смерти 1 (pd-1) и способы лечения рака с использованием анти-pd-1-антител самостоятельно или в комбинации с другими иммунотерапевтическими средствами
|
|
WO2007002223A2
(en)
|
2005-06-20 |
2007-01-04 |
Medarex, Inc. |
Cd19 antibodies and their uses
|
|
CN104356236B
(zh)
|
2005-07-01 |
2020-07-03 |
E.R.施贵宝&圣斯有限责任公司 |
抗程序性死亡配体1(pd-l1)的人单克隆抗体
|
|
HUE035853T2
(en)
|
2005-07-18 |
2018-05-28 |
Seattle Genetics Inc |
Beta-glucuronide-linker-drug conjugates
|
|
CA2620933A1
(en)
|
2005-09-02 |
2007-03-08 |
Pfizer Inc. |
Hydroxy substituted 1h-imidazopyridines and methods
|
|
WO2007034917A1
(ja)
|
2005-09-22 |
2007-03-29 |
Dainippon Sumitomo Pharma Co., Ltd. |
新規なアデニン化合物
|
|
EP1939202A4
(en)
|
2005-09-22 |
2010-06-16 |
Dainippon Sumitomo Pharma Co |
NEW ADENINE CONNECTION
|
|
CA2623236A1
(en)
|
2005-09-26 |
2007-04-05 |
Medarex, Inc. |
Human monoclonal antibodies to cd70
|
|
BRPI0617546A2
(pt)
|
2005-09-26 |
2011-07-26 |
Medarex Inc |
conjugado de fÁrmaco-anticorpo, formulaÇço farmacÊutica, mÉtodo para matar uma cÉlula de tumor, mÉtodo para retardar ou interromper o crescimento de um tumor em um sujeito mamÍfero e composto
|
|
SI1940789T1
(sl)
|
2005-10-26 |
2012-03-30 |
Medarex Inc |
Postopki in spojine za pripravo cc analogov
|
|
CA2627190A1
(en)
|
2005-11-10 |
2007-05-24 |
Medarex, Inc. |
Duocarmycin derivatives as novel cytotoxic compounds and conjugates
|
|
EA017812B1
(ru)
|
2005-12-08 |
2013-03-29 |
Медарекс, Инк. |
Выделенное моноклональное антитело или его антигенсвязывающий участок, которые связываются с протеинтирозинкиназой 7 ( ptk7) человека, и их применение
|
|
AU2006321553B2
(en)
|
2005-12-08 |
2012-03-08 |
E. R. Squibb & Sons, L.L.C. |
Human monoclonal antibodies to O8E
|
|
WO2007093901A1
(en)
|
2006-02-17 |
2007-08-23 |
Pfizer Limited |
3 -deazapurine derivatives as tlr7 modulators
|
|
DK2035554T3
(da)
|
2006-06-29 |
2013-06-17 |
Univ Leland Stanford Junior |
Celle-fri syntese af proteiner indeholdende ikke-naturlige aminosyrer
|
|
JP2010500886A
(ja)
|
2006-08-18 |
2010-01-14 |
ノボ ノルディスク ヘルス ケア アーゲー |
改善された特異性を有するトランスグルタミナーゼ変異体
|
|
EP2064316B1
(en)
|
2006-09-08 |
2012-01-25 |
Ambrx, Inc. |
Site specific incorporation of non-natural amino acids by vertebrate cells
|
|
KR101722261B1
(ko)
|
2006-10-02 |
2017-04-03 |
메다렉스, 엘.엘.시. |
Ｃｘｃｒ4에 결합하는 인간 항체 및 이의 용도
|
|
KR101552735B1
(ko)
|
2006-12-01 |
2015-09-14 |
메다렉스, 엘.엘.시. |
씨디22에 결합하는 인간 항체 및 이의 용도
|
|
UY30776A1
(es)
|
2006-12-21 |
2008-07-03 |
Medarex Inc |
Anticuerpos cd44
|
|
TWI412367B
(zh)
|
2006-12-28 |
2013-10-21 |
梅達雷克斯有限責任公司 |
化學鏈接劑與可裂解基質以及其之綴合物
|
|
ES2552471T3
(es)
|
2007-02-07 |
2015-11-30 |
The Regents Of The University Of California |
Conjugados de agonistas de TLR sintéticos y usos de los mismos
|
|
CA2678514A1
(en)
|
2007-02-21 |
2008-08-28 |
Medarex, Inc. |
Chemical linkers with single amino acids and conjugates thereof
|
|
KR20090123857A
(ko)
|
2007-02-22 |
2009-12-02 |
노보 노르디스크 헬스 케어 악티엔게젤샤프트 |
특이성이 개선된 트랜스글루타미나아제 변이체
|
|
AR065784A1
(es)
|
2007-03-20 |
2009-07-01 |
Dainippon Sumitomo Pharma Co |
Derivados de 8-oxo adenina,medicamentos que los contienen y usos como agentes terapeuticos para enfermedades alergicas, antivirales o antibacterianas.
|
|
WO2008118454A2
(en)
|
2007-03-23 |
2008-10-02 |
Amgen Inc. |
Derivatives of quinoline or benzopyrazine and their uses for the treatment of (inter alia) inflammatory diseases, autoimmune diseases or various kinds of cancer
|
|
CA2691444C
(en)
|
2007-06-29 |
2016-06-14 |
Gilead Sciences, Inc. |
Purine derivatives and their use as modulators of toll-like receptor 7
|
|
CA2707030A1
(en)
|
2007-08-03 |
2009-02-12 |
Pfizer Limited |
Imidazopyridinones
|
|
EP2185188B1
(en)
|
2007-08-22 |
2014-08-06 |
Medarex, L.L.C. |
Site-specific attachment of drugs or other agents to engineered antibodies with c-terminal extensions
|
|
CA2700860C
(en)
|
2007-10-01 |
2016-07-19 |
Jonathan A. Terrett |
Human antibodies that bind mesothelin, and uses thereof
|
|
ES2467108T3
(es)
|
2008-12-09 |
2014-06-11 |
Gilead Sciences, Inc. |
Moduladores de receptores tipo toll
|
|
WO2010087994A2
(en)
|
2009-01-30 |
2010-08-05 |
Whitehead Institute For Biomedical Research |
Methods for ligation and uses thereof
|
|
KR20110117705A
(ko)
|
2009-02-11 |
2011-10-27 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
톨-유사 수용체 조정제 및 질병의 치료
|
|
US8962652B2
(en)
|
2009-10-22 |
2015-02-24 |
Gilead Sciences, Inc. |
Derivatives of purine or deazapurine useful for the treatment of (inter alia) viral infections
|
|
NZ603155A
(en)
|
2010-04-30 |
2014-06-27 |
Telormedix Sa |
Phospholipid drug analogs
|
|
US20130202629A1
(en)
|
2010-04-30 |
2013-08-08 |
The Regents Of The University Of California |
Uses of phospholipid conjugates of synthetic tlr7 agonists
|
|
WO2011134669A1
(en)
|
2010-04-30 |
2011-11-03 |
Telormedix Sa |
Methods for inducing an immune response
|
|
US20120083473A1
(en)
|
2010-09-21 |
2012-04-05 |
Johanna Holldack |
Treatment of conditions by toll-like receptor modulators
|
|
US9676871B2
(en)
|
2010-11-05 |
2017-06-13 |
Pfizer Inc. |
Engineered polypeptide conjugates and methods for making thereof using transglutaminase
|
|
TW201247706A
(en)
|
2011-03-08 |
2012-12-01 |
Baylor Res Inst |
Novel vaccine adjuvants based on targeting adjuvants to antibodies directly to antigen-presenting cells
|
|
JP2014521687A
(ja)
|
2011-07-29 |
2014-08-28 |
セレクタ バイオサイエンシーズ インコーポレーテッド |
体液性および細胞傷害性ｔリンパ球（ｃｔｌ）免疫応答を生成する合成ナノキャリア
|
|
RS57851B1
(sr)
|
2011-11-09 |
2018-12-31 |
Janssen Sciences Ireland Uc |
Purinski derivati za tretman viralnih infekcija
|
|
CA2874800C
(en)
|
2012-07-13 |
2021-04-06 |
Janssen R&D Ireland |
Macrocyclic purines for the treatment of viral infections
|
|
ES2653254T3
(es)
|
2012-08-24 |
2018-02-06 |
Glaxosmithkline Llc |
Compuestos de pirazolopirimidina
|
|
LT2906563T
(lt)
|
2012-10-10 |
2018-06-11 |
Janssen Sciences Ireland Uc |
Pirolo[3,2-d]pirimidino dariniai virusinių infekcijų ir kitų ligų gydymui
|
|
EP2732825B1
(en)
|
2012-11-19 |
2015-07-01 |
Invivogen |
Conjugates of a TLR7 and/or TLR8 agonist and a TLR2 agonist
|
|
RS56169B1
(sr)
|
2013-02-14 |
2017-11-30 |
Bristol Myers Squibb Co |
Jedinjenja tubulisina, metode pripreme i primena
|
|
US9295732B2
(en)
|
2013-02-22 |
2016-03-29 |
Invivogen |
Conjugated TLR7 and/or TLR8 and TLR2 polycationic agonists
|
|
AU2014242954B2
(en)
|
2013-03-29 |
2018-03-15 |
Janssen Sciences Ireland Uc |
Macrocyclic deaza-purinones for the treatment of viral infections
|
|
BR112015032546B1
(pt)
|
2013-06-27 |
2022-05-17 |
Janssen Sciences Ireland Uc |
Derivados de pirrolo[3,2-d]pirimidina e composição farmacêutica que os compreende para o tratamento de infecções virais e outras doenças
|
|
EP3033089A2
(en)
|
2013-08-16 |
2016-06-22 |
The Regents of The University of California |
Uses of phospholipid conjugates of synthetic tlr7 agonists
|
|
WO2015036044A1
(en)
|
2013-09-13 |
2015-03-19 |
Telormedix Sa |
Cationic lipid vehicles for delivery of tlr7 agonists for specific targeting of human cd14+ monocytes in whole blood
|
|
EP3129373B1
(en)
*
|
2014-04-11 |
2021-09-01 |
Taipei Medical University |
Histone deacetylase inhibitors
|
|
JP6484253B2
(ja)
|
2014-05-01 |
2019-03-13 |
ノバルティス アーゲー |
Ｔｏｌｌ様受容体７アゴニストとしての化合物および組成物
|
|
EA032487B1
(ru)
|
2014-05-01 |
2019-06-28 |
Новартис Аг |
Соединения и композиции в качестве агонистов toll-подобного рецептора 7
|
|
WO2015171527A1
(en)
*
|
2014-05-05 |
2015-11-12 |
Global Blood Therapeutics, Inc. |
Pyrazolopyridine pyrazolopyrimidine and related compounds
|
|
CR20160525A
(es)
*
|
2014-05-14 |
2016-12-20 |
Pfizer |
Pirazolopiridinas y pirazolopirimidinas
|
|
CN105367576A
(zh)
*
|
2014-08-15 |
2016-03-02 |
正大天晴药业集团股份有限公司 |
作为tlr7激动剂的吡咯并嘧啶化合物
|
|
HUE054672T2
(hu)
|
2014-08-15 |
2021-09-28 |
Chia Tai Tianqing Pharmaceutical Group Co Ltd |
TLR7 agonistaként alkalmazott pirrolopirimidin vegyületek
|
|
UY36391A
(es)
*
|
2014-11-05 |
2016-06-01 |
Flexus Biosciences Inc |
Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido1), sus métodos de síntesis y composiciones farmacèuticas que las contienen
|
|
CN105732635A
(zh)
|
2014-12-29 |
2016-07-06 |
南京明德新药研发股份有限公司 |
一类Toll样受体7激动剂
|
|
CN107406496A
(zh)
|
2015-03-10 |
2017-11-28 |
百时美施贵宝公司 |
可通过转谷氨酰胺酶缀合的抗体和由其制备的缀合物
|
|
BR112018000624A2
(pt)
*
|
2015-07-15 |
2018-09-18 |
Aurigene Discovery Technologies Limited |
compostos de indazol e azaindazol como inibidores de irak-4
|
|
CN108472386A
(zh)
|
2015-10-02 |
2018-08-31 |
百时美施贵宝公司 |
用于缀合抗体的转谷氨酰胺酶变体
|
|
TN2018000112A1
(en)
|
2015-10-29 |
2019-10-04 |
Novartis Ag |
Antibody conjugates comprising toll-like receptor agonist
|
|
CA3004173C
(en)
|
2015-11-05 |
2020-07-14 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
7-(thiazol-5-yl)pyrrolopyrimidine compound as tlr7 agonist
|
|
WO2017100557A1
(en)
|
2015-12-11 |
2017-06-15 |
Graphic Packaging International, Inc. |
Container with absorption features
|
|
WO2017197056A1
(en)
*
|
2016-05-10 |
2017-11-16 |
C4 Therapeutics, Inc. |
Bromodomain targeting degronimers for target protein degradation
|
|
WO2017216293A1
(en)
|
2016-06-16 |
2017-12-21 |
Janssen Pharmaceutica Nv |
Azabenzimidazole derivatives as pi3k beta inhibitors
|
|
CN109715214B
(zh)
|
2016-09-13 |
2022-03-04 |
豪夫迈·罗氏有限公司 |
Tlr7激动剂和hbv衣壳组装抑制剂的组合治疗
|
|
RU2748833C2
(ru)
|
2016-11-28 |
2021-05-31 |
Цзянсу Хэнжуй Медсин Ко., Лтд. |
Производное пиразоло-гетероарила, способ его получения и медицинское применение
|
|
US10508115B2
(en)
|
2017-08-16 |
2019-12-17 |
Bristol-Myers Squibb Company |
Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses therefor
|
|
US10487084B2
(en)
|
2017-08-16 |
2019-11-26 |
Bristol-Myers Squibb Company |
Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses therefor
|
|
US10457681B2
(en)
|
2017-08-16 |
2019-10-29 |
Bristol_Myers Squibb Company |
Toll-like receptor 7 (TLR7) agonists having a tricyclic moiety, conjugates thereof, and methods and uses therefor
|
|
US10472361B2
(en)
|
2017-08-16 |
2019-11-12 |
Bristol-Myers Squibb Company |
Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates thereof, and methods and uses therefor
|
|
US10494370B2
(en)
|
2017-08-16 |
2019-12-03 |
Bristol-Myers Squibb Company |
Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses therefor
|
|
KR20200103040A
(ko)
|
2017-12-21 |
2020-09-01 |
다이닛본 스미토모 세이야꾸 가부시끼가이샤 |
Tlr7 아고니스트를 포함하는 병용 약물
|
|
WO2019209811A1
(en)
|
2018-04-24 |
2019-10-31 |
Bristol-Myers Squibb Company |
Macrocyclic toll-like receptor 7 (tlr7) agonists
|
|
US11554120B2
(en)
*
|
2018-08-03 |
2023-01-17 |
Bristol-Myers Squibb Company |
1H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists and methods and uses therefor
|
|
US11664120B1
(en)
*
|
2020-05-11 |
2023-05-30 |
Walgreen Co. |
Apparatuses, systems, and methods for reducing return of prescriptions to stock
|